[Experimental therapy with so-called "minor" tuberculostatics].
D000636:Aminosalicylic Acids / Q000627:therapeutic use*; D000818:Animals; D000995:Antitubercular Agents / Q000627:therapeutic use*; D003523:Cycloserine / Q000627:therapeutic use*; D004977:Ethambutol / Q000627:therapeutic use; D005000:Ethionamide / Q000627:therapeutic use*; D006168:Guinea Pigs; D007612:Kanamycin / Q000627:therapeutic use*; D051379:Mice; D010670:Phenylthiourea / Q000031:analogs & derivatives / Q000627:therapeutic use; D011718:Pyrazinamide / Q000627:therapeutic use*; D011817:Rabbits; D014376:Tuberculosis / Q000188:drug therapy; D014379:Tuberculosis, Avian / Q000188:drug therapy
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D011718:Pyrazinamide; D007612:Kanamycin; D010670:Phenylthiourea; D004977:Ethambutol; D003523:Cycloserine; D005000:Ethionamide
Zur experimentellen Therapie mit den sogenannten "kleinen" Tuberkulostatika.